On March 24–25, 2026, the General Assembly of the Italian National Transplant Network took place at the National Research Council (CNR) in Rome, representing one of the key moments of dialogue among institutions, the scientific community, and healthcare professionals.
The event provided an important opportunity to analyze the record-breaking results achieved by the Italian transplant system – with 2025 marked as the best year ever – and to discuss future perspectives, including technological innovation, sustainability, and the harmonization of standards at both national and European levels.
In this context, Avantea participated through the presence of Prof. Cesare Galli, one of the leading experts in organ transplantation in Italy.
During the session dedicated to xenotransplantation, chaired by Prof. Giuseppe Remuzzi of IRCCS Mario Negri, Prof. Cozzi from the University of Padua introduced the topic of xenotransplantation, Mons. Renzo Pegoraro, President of the Pontifical Academy for Life, presented the Academy’s position paper on xenotransplantation, and Prof. Galli delivered a lecture on the current state of the art in the development of pig lines for xenotransplantation, contributing to the discussion on one of the most advanced and promising frontiers of modern medicine.
Xenotransplantation today represents a potential structural response to the shortage of available organs, while also requiring a rigorous scientific, regulatory, and ethical approach. These themes were central throughout the entire event.
Avantea’s participation confirms the role of its biotech division as a bridge between advanced research and medical applications, in line with the evolution of translational medicine.
The expertise developed in assisted reproduction, genetics, and advanced animal models naturally extends to fields such as xenotransplantation, where scientific research, biotechnology, and innovation play a crucial role.
Being present at the General Assembly of the National Transplant Network means actively contributing to a dialogue that goes beyond sector boundaries, helping shape the future directions of biomedical research.
Highlighting the importance of the initiative, participants were welcomed at the Vatican and received by Pope Leo XIV, in a high-level institutional moment that reaffirmed the value of science oriented toward the good of the person, capable of combining technological progress with ethical responsibility.